Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth
The role will focus on identifying new opportunities and strengthening existing customer relationships to accelerate Ritedose’s continued growth.
READ MORE
IN THE NEWS
Ritedose news
and updates.
Learn more about Ritedose and the community.
Press releases, news stories, partnerships, community events, and more.
Media Inquiries
Schedule your interview and learn more about the Ritedose Company.
One Size No Longer Fits All in Pharmaceutical Manufacturing
Specialized CDMOs combine precision, agility and scale to meet the evolving needs of complex pharmaceutical manufacturing. This is production on purpose.
READ MORE
Resilience Is a Commitment to Learning
Discover how learning, quality and continuous improvement help Ritedose build resilience and strengthen pharmaceutical manufacturing.
READ MORE
Patient Behavior Drives a Better Design
Learn how patient behavior can inform pharmaceutical product design, packaging and delivery to create safer, more intuitive therapies.
READ MORE
Hidden Contamination: What Preservative-Free Ophthalmic Patients Need to Know
Learn how Blow-Fill-Seal manufacturing supports ophthalmic sterility and why proper handling of single-use ophthalmic products is essential to preventing microbial contamination.
READ MORE
Why Reclosing a Single-Use Ophthalmic Vial Doesn’t Restore Sterility
A vial may look protected after being closed again, but sterility cannot be restored once a single-use ophthalmic vial has been opened.
READ MORE
Ritedose Commits to National “Hope Alliance” Campaign to Support Uninsured Patients
The leader in unit dose sterile medications pledges to the Dispensary of Hope a long-term supply of critical respiratory medications to stabilize care for vulnerable populations.
READ MORE
Purpose at Scale: What “Driven by Purpose” Looks Like in Pharmaceutical Manufacturing
Ritedose explores how purpose-driven pharmaceutical manufacturing strengthens quality, innovation and patient-centered care.
READ MORE
Eyedrop recall underscores need for quality focus
An FDA eye drop recall involving sterility concerns highlights the critical role of cGMP compliance, aseptic processing, and Blow-Fill-Seal technology in safe ophthalmic drug manufacturing.
READ MORE
Why Pharmaceutical Resilience Is Critical in Drug Manufacturing
Pharmaceutical resilience is essential to strengthening the U.S. drug supply chain against shortages, global dependencies, and emerging risks.
READ MORE
Ritedose Reaches “1,000 Hours of Purpose”
Employee-led initiative deepens Ritedose’s commitment to Midlands nonprofits and the communities they serve.
READ MORE
Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing
– Collaboration showcases the Ritedose Center of Excellence as a global hub for advanced manufacturing education. – The Center of Excellence serves as a cornerstone of Ritedose’s broader commitment to workforce development and industry leadership.
READ MORE
What Does it Mean to be a Manufacturer of Choice?
Ritedose explains how quality, reliability, and Blow-Fill-Seal (BFS) expertise define what it means to be a true manufacturer of choice in pharmaceutical manufacturing.
READ MORE
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic Treatment.
READ MORE
Meeting Patient Needs Through Flexible Pharmaceutical Manufacturing
Pharmaceutical manufacturing at scale requires flexibility, cGMP compliance and advanced technology to ensure safe, reliable medications for patients.
READ MORE
Blow-Fill-Seal: How Ritedose Is Setting the Standard in Pharmaceutical Manufacturing
Blow-Fill-Seal manufacturing is transforming sterile pharmaceutical production, and Ritedose is setting the standard through innovation, quality systems and scalable CDMO expertise.
READ MORE
How Ritedose Addresses Drug Shortages
Ritedose helps address drug shortages by using advanced sterile manufacturing and strategic partnerships to keep essential treatments available.
READ MORE
Ritedose Honored With SCbio’s 2026 Life Sciences Pinnacle Award for Organizational Contribution
South Carolina’s largest sterile CDMO recognized for visionary leadership, innovation, and community impact at SCbio’s annual Life + Science Conference.
READ MORE
South Carolina Life Sciences Momentum: Ritedose Helps Fuel a Fast-Growing Innovation Hub
Ritedose is helping shape a new era of innovation in South Carolina, where life sciences companies are scaling faster than ever before.
READ MORE
Introducing Ritedose— the Largest CDMO Specializing in Blow-Fill-Seal Technology in the US
This overview explores Ritedose, the largest U.S. pharmaceutical CDMO, and how its aseptic Blow-Fill-Seal technology supports large-scale branded and generic drug manufacturing.
READ MORE
FEATURED NEWS
RECEIVE THE LATEST NEWS
Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.